Ear injection could restore hearing in diabetics
NCT ID NCT07472907
First seen Mar 26, 2026 · Last updated May 22, 2026 · Updated 6 times
Summary
This study tests a single injection of CIL001 into the ear to repair hearing damage caused by type 2 diabetes. The treatment aims to improve the ability to understand speech in noisy environments. About 135 adults aged 45-75 with type 2 diabetes and hearing loss will participate. The main goal is to check safety and measure how well the treatment works.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for COCHLEAR SYNAPTOPATHY are added.
By submitting, you agree to our Terms of use
Conditions
Explore the condition pages connected to this study.